{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:39:43Z","timestamp":1782333583711,"version":"3.54.5"},"reference-count":95,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/21645515.2026.2627097","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:25:59Z","timestamp":1773152759000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Safety, immunogenicity, and effectiveness of the MAV\/06 varicella vaccine: A comprehensive review of a new strain vaccine"],"prefix":"10.1080","volume":"22","author":[{"given":"Younchul","family":"Shin","sequence":"first","affiliation":[{"name":"GC Biopharma Corp","place":["Yongin, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunji","family":"Ryu","sequence":"additional","affiliation":[{"name":"GC Biopharma Corp","place":["Yongin, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwanglok","family":"Kim","sequence":"additional","affiliation":[{"name":"GC Biopharma Corp","place":["Yongin, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinha","family":"Yang","sequence":"additional","affiliation":[{"name":"GC Biopharma Corp","place":["Yongin, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewoo","family":"Lee","sequence":"additional","affiliation":[{"name":"GC Biopharma Corp","place":["Yongin, Republic of Korea"]},{"name":"Ajou University","place":["Suwon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7087-9378","authenticated-orcid":false,"given":"BongKyoo","family":"Choi","sequence":"additional","affiliation":[{"name":"GC Biopharma Corp","place":["Yongin, Republic of Korea"]},{"name":"Sungkyunkwan University","place":["Suwon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/9781555815981.ch21"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/v10070349"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3215"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.16"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/C2013-0-18914-3"},{"issue":"100","key":"e_1_3_4_7_1","first-page":"567","article-title":"WHO position paper on varicella vaccines \u2013 November 2025","volume":"47","year":"2025","unstructured":"WHO position paper on varicella vaccines \u2013 November 2025. World Health Organization. 2025;47(100):567\u2013590.","journal-title":"World Health Organization"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10319"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.017814-0"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.00752-15"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.11.007"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/157339609791317315"},{"issue":"6","key":"e_1_3_4_13_1","first-page":"750","article-title":"Age-specific incidence of chickenpox","volume":"109","author":"Finger R","year":"1994","unstructured":"Finger R, Hughes JP, Meade BJ, Pelletier AR, Palmer CT. Age-specific incidence of chickenpox. Public Health Rep. 1994;109(6):750\u2013755.","journal-title":"Public Health Rep"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.64.131"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1305"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.4.698"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2021.01564"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac251"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac242"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1546525"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2045152"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-7-26"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003448"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100639"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2013.847529"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S229685"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251644"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(99)00115-X"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254080"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2815-9"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-022-01678-5"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28590"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1086\/315335"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.22.11447-11459.2002"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-547"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00998-16"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.12.033"},{"key":"e_1_3_4_38_1","first-page":"105","article-title":"Marker test for attenuation of varicella-zoster viruses isolated in Korea","volume":"22","author":"Hwang KK","year":"1992","unstructured":"Hwang KK, Chun BH, Park HS, Park SY, Kim KY, Moon HM. Marker test for attenuation of varicella-zoster viruses isolated in Korea. J Kor Soc Virol. 1992;22:105\u2013109.","journal-title":"J Kor Soc Virol"},{"key":"e_1_3_4_39_1","first-page":"1","article-title":"Propagation of varicella-zoster virus isolated in Korea","volume":"21","author":"Park SY","year":"1991","unstructured":"Park SY, Hwang KK, Choi MK, Ryu YW, Paik SB, Kim KH. Propagation of varicella-zoster virus isolated in Korea. J Kor Soc Virol. 1991;21:1\u20139.","journal-title":"J Kor Soc Virol"},{"key":"e_1_3_4_40_1","unstructured":"Who prequalified vaccines. https:\/\/extranet.who.int\/prequal\/vaccines\/prequalified-vaccines."},{"key":"e_1_3_4_41_1","first-page":"1405","article-title":"Safety and immunogenicity of live attenuated varicella virus vaccine (MAV\/06 strain)","volume":"37","author":"Sohn YM","year":"1994","unstructured":"Sohn YM, Park CY, Hwang KK, Woo GJ, Park SY. Safety and immunogenicity of live attenuated varicella virus vaccine (MAV\/06 strain). Kor Pediatr Soc. 1994;37:1405\u20131413.","journal-title":"Kor Pediatr Soc"},{"issue":"6","key":"e_1_3_4_42_1","first-page":"794","article-title":"A study on the immunogenicity and safety of a live attenuated varicella vaccine (MAV\/06 strain) in immunocompromised children","volume":"38","author":"Son YM","year":"1995","unstructured":"Son YM, Lew CJ, Kim KY, Park JY, Kim MR, Jeong WG, Hwang GG, Woo GJ, Park SY. A study on the immunogenicity and safety of a live attenuated varicella vaccine (MAV\/06 strain) in immunocompromised children. J Korean Pediatr Soc. 1995;38(6):794\u2013804.","journal-title":"J Korean Pediatr Soc"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.02.013"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11091442"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/149.6.956"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/82-2010-14"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1086\/510532"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2016.06.017"},{"key":"e_1_3_4_49_1","unstructured":"Ko EB Park HI Park HM Shin SK. Periodic benefit risk evaluation report for: varicella vaccine-GCC Inj._ver4.0; GC Biopharma Yongin-si Gyeonggi-do Republic of Korea. Unpublished Report 2022."},{"key":"e_1_3_4_50_1","unstructured":"Information approved by the Ministry of Food and Drug Safety of the Republic of Korea for BARYCELA. https:\/\/nedrug.mfds.go.kr\/searchDrug."},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40629-022-00215-8"},{"key":"e_1_3_4_52_1","unstructured":"Barycela package insert. https:\/\/extranet.who.int\/prequal\/sites\/default\/files\/vwa_vaccine\/pq_381_varicella__GC_PI-2023.pdf."},{"key":"e_1_3_4_53_1","unstructured":"Information approved by the Ministry of Food and Drug Safety of the Republic of Korea for SKYvaricella. https:\/\/nedrug.mfds.go.kr\/searchDrug."},{"key":"e_1_3_4_54_1","unstructured":"Varivax package insert. https:\/\/www.fda.gov\/media\/76008\/download?Attachment."},{"key":"e_1_3_4_55_1","unstructured":"Varilrix product monograph. https:\/\/ca.gsk.com\/Media\/6263\/Varilrix.Pdf."},{"key":"e_1_3_4_56_1","unstructured":"Skyvaricella package insert. https:\/\/extranet.who.int\/prequal\/sites\/default\/files\/vwa_vaccine\/pq_347_varicella_1dose_SK_PI-2019.pdf."},{"key":"e_1_3_4_57_1","unstructured":"Information approved by the Ministry of Food and Drug Safety of the Republic of Korea for varicella vaccine-GCC. https:\/\/nedrug.mfds.go.kr\/searchDrug."},{"key":"e_1_3_4_58_1","unstructured":"Varicella vaccine-GCC package insert. https:\/\/www.globalgreencross.com\/eng\/index.do."},{"key":"e_1_3_4_59_1","unstructured":"Drug Regulatory Authority of Pakistan. (T.F. Complex Mauve area G-9\/4 Islamabad Pakistan). Minutes of 329th meeting of registration board Held on 6th to 8th June 2023_Pakistan. Unpublished work 2023."},{"key":"e_1_3_4_60_1","unstructured":"T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 T\u00fcrkiye \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu. Ruhsatname. 2024. Unpublished document."},{"key":"e_1_3_4_61_1","unstructured":"S\u1ed1:\/Q\u0110-QLD V\u1ec1 vi\u1ec7c ban h\u00e0nh Danh m\u1ee5c 25 v\u1eafc xin sinh ph\u1ea9m \u0111\u01b0\u1ee3c c\u1ea5p gia h\u1ea1n gi\u1ea5y \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam - \u0110\u1ee3t 56. Unpublished work 2025."},{"key":"e_1_3_4_62_1","unstructured":"Park HI Kim JA Park HM Shin SK. Periodic benefit risk evaluation report for: BARYCELA Inj._ver6.0; GC Biopharma Yongin-si Gyeonggi-do Republic of Korea. Unpublished Report 2024."},{"key":"e_1_3_4_63_1","unstructured":"Expanded program of immunization vaccine prices for year 2021. https:\/\/www.paho.org\/en\/documents\/paho-revolving-fund-vaccine-prices-2021."},{"key":"e_1_3_4_64_1","unstructured":"Expanded program of immunization vaccine prices for year 2023. https:\/\/www.paho.org\/en\/documents\/paho-revolving-fund-vaccine-prices-2023."},{"key":"e_1_3_4_65_1","unstructured":"Expanded program of immunization vaccine prices for year 2022. https:\/\/www.paho.org\/en\/documents\/paho-revolving-fund-vaccine-prices-2022."},{"key":"e_1_3_4_66_1","unstructured":"Gonzales MALM Gonzaga EM. Final report_immunogenicity and safety of a new live attenuated varicella vaccine (MAV\/06 strain) among healthy Filipino children of ages 9 months to 17 years; GC Biopharma Yongin-si Gyeonggi-do Republic of Korea. Unpublished Report 2001."},{"key":"e_1_3_4_67_1","unstructured":"Lim DS. Clinical study report_MG1111_P1 _ve 1.0; 2015; GC Biopharma Yongin-si Gyeonggi-do Republic of Korea. Unpublished Report 2015."},{"key":"e_1_3_4_68_1","unstructured":"Dose-escalation phase 1 to evaluate the safety and efficacy of MG1111 in healthy adults. https:\/\/clinicaltrials.gov\/study\/NCT02367638?cond=mg1111&rank=2."},{"key":"e_1_3_4_69_1","unstructured":"Kang JH. Clinical study report_MG1111_P2 3_stage1 2; 2018; GC Biopharma Yongin-si Gyeonggi-do Republic of Korea. Unpublished Report 2018."},{"key":"e_1_3_4_70_1","unstructured":"A study of MG1111 in healthy children. https:\/\/clinicaltrials.gov\/study\/NCT03375502?cond=mg1111&rank=1."},{"key":"e_1_3_4_71_1","unstructured":"An open-label bridging study of BARYCELA Inj. in healthy Vietnamese children aged between 12 months to 12 years. https:\/\/clinicaltrials.gov\/study\/NCT05664152?cond=mg1111&rank=3."},{"key":"e_1_3_4_72_1","unstructured":"Minh Giang L. Clinical study report_bridging study for marketing authorization in Vietnam_ver2.0; 2024; GC Biopharma Yongin-si Gyeonggi-do Republic of Korea. Unpublished Report 2024."},{"key":"e_1_3_4_73_1","unstructured":"ICH guideline E2C (R2) on periodic benefit-risk evaluation report (PBRER) https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use-guideline-e2c-r2-periodic-benefit-risk-evaluation-report-step-5_en.pdf."},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.08.044"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1086\/522125"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00297-8"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2010.04.001"},{"key":"e_1_3_4_78_1","volume-title":"The immunological basis for immunization series: module 10: varicella-zoster virus. 20 avenue Appia, 1211 Geneva 27, Switzerland: immunization, vaccines and biologicals","author":"Gershon AA","year":"2008","unstructured":"Gershon AA. The immunological basis for immunization series: module 10: varicella-zoster virus. 20 avenue Appia, 1211 Geneva 27, Switzerland: immunization, vaccines and biologicals. WHO; 2008."},{"key":"#cr-split#-e_1_3_4_79_1.1","unstructured":"Gonzaga EM. Final report_a 5-year follow-up immunogenicity study for a live attenuated varicella vaccine (MAV\/06 strain) among healthy Filipino children immunized at ages 9 months to 17 years from May 2000 to April 2001_ver1.0"},{"key":"#cr-split#-e_1_3_4_79_1.2","unstructured":"GC Biopharma Yongin-si Gyeonggi-do Republic of Korea. Unpublished Report 2006."},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1190056"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1086\/529043"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-022-00503-6"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1086\/344228"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.03.054"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2210961"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1603985"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e53"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e200"},{"key":"e_1_3_4_89_1","first-page":"1016","volume-title":"Proceedings of the 38th International Conference for Pharmacoepidemiology, GC Bioharma","author":"Cho H","year":"2022","unstructured":"Cho H, Sun E, Jeon S, Ann S, Choi B. Trends in the incidence of varicella cases with complications among Korean children during 2010-2020 after the universal one-dose varicella vaccination program. Proceedings of the 38th International Conference for Pharmacoepidemiology, GC Bioharma; 2022. Copenhagen, Denmark. p. 1016."},{"issue":"1","key":"e_1_3_4_90_1","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e17","article-title":"Letter to the Editor: Effectiveness of the Varicella Vaccine Among Korean Children: Suggestions for Future Research","volume":"37","author":"Choi B","year":"2022","unstructured":"Choi B, Cho H, Shin Y, Lee EK. Letter to the Editor: Effectiveness of the Varicella Vaccine Among Korean Children: Suggestions for Future Research. J Korean Med Sci. 2022;37(1):e17.","journal-title":"J Korean Med Sci"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e222"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2017.07.029"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199912000-00004"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1086\/522124"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.3346\/JKMS.2022.37.E17"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2627097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:26:14Z","timestamp":1773152774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2026.2627097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/21645515.2026.2627097"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2026.2627097","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2627097"}}